Gastroenterology Report-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2024-07-27 ms1000001125993525 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：普外科
经验分享：版面费多少呢？可以选择非OA吗？

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2023-07-25 婆婆丁来自广东省

awaiting recommendation一般持续多久

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2024-03-13 李卫秀来自四川省

去

83 0

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2024-03-13 李卫秀来自四川省

无

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2023-10-08 c040149 来自浙江省

偏重的研究方向：EUS
经验分享：目前Awaiting Reviewer Selection 状态

84 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2023-04-27 147470b1m83暂无昵称来自湖南省

请问waiting reviewer selection是已经决定送审，在找审稿人吗？

122 0

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2021-01-27 Godmin

投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？

195 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

SCI文章有哪些类型？

165 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

什么是SCI？

155 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217086, encodeId=f43a221e08690, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：普外科 经验分享：版面费多少呢？可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ee5472482, createdName=ms1000001125993525, createdTime=Sat Jul 27 16:13:21 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS 经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=)]

2020-04-26 EthanYan

审稿速度:3.0 | 投稿命中率:50.0
经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！

240 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务